Home Molecular Axiom

Molecular Axiom

Out of service
Series A
Nucleic Acid Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Molecular Axiom focuses on the discovery, clinical development, and commercialization of nucleic acid drugs. Its core strengths encompass multi-platform RNA technologies, including ASO, RNAi, mRNA, and drug delivery technologies such as LNP, aiming to create highly differentiated nucleic acid drugs targeting high-value biological pathways to address significant unmet medical needs.
Molecular Axiom
Shanghai,China
unclear
August 16, 2022
--
info@molecularaxiom.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Application Scenarios
Innovative Drugs Nucleic Acid Drugs Small Nucleic Acid Drugs